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Positional studiesAlyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS.NH2), ﬁrst isolated from skin secretions of the midwife toad Alytes
obstetricans, shows selective growth-inhibitory activity against Gram-negative bacteria. The structures of
alyteserin-1c and its more potent and less haemolytic analogue [E4K]alyteserin-1c were investigated in various
solution and membrane mimicking environments by proton NMR spectroscopy and molecular modelling. In
aqueous solution, the peptide displays a lack of secondary structure but, in a 2,2,2-triﬂuoroethanol (TFE-d3)-H2O
solvent mixture, the structure is characterised by an extended alpha helix between residues Leu2 and Val21.
Solution structural studies in the membrane mimicking environments, sodium dodecyl sulphate (SDS),
dodecylphosphocholine (DPC), and 1,2-dihexanoyl-sn-glycero-3-phosphatidylcholine (DHPC)micelles, indicate
that these peptides display an alpha helical structure between residues Lys3 and Val21. Positional studies of the
peptides in SDS, DPC and DHPCmedia show that the N-terminal and central residues lie inside themicelle while
C-terminal residues beyond Ala19 do not interact with the micelles.3-phosphatidylcholine; DPC,
, nuclear magnetic resonance;
user effect spectroscopy; SDS,
total correlation spectroscopy;
+353 1 716 6893.
wage).
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The emergence of pathogenic strains of bacteria and fungi with
resistance to commonly used antibiotics constitutes a serious threat to
public health andhasnecessitated a search fornewtypesof antimicrobial
agents [1]. Although some effective new types of antibiotics against
multidrug-resistant Gram-positive bacteria, such asmethicillin-resistant
Staphylococcus aureus (MRSA) have been introduced or are in clinical
trials, the situation regarding new treatment options for infections
produced by emerging multidrug-resistant Gram-negative pathogens
such as Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae,
and Pseudomonas aeruginosa is less encouraging [2].
Peptides with antimicrobial activity play an important role in the
innate immunity that predates adaptive immunity and constitutes
the ﬁrst-line defence against invading pathogens for a wide range of
vertebrate and invertebrate species [3]. Compounds based upon these
naturally occurring anti-infective peptides are receiving serious at-
tention as potential therapeutic agents [4]. Although there is no single
mechanism by which peptides produce cell death, binding to speciﬁc
receptors on the cell membrane is not involved, rather a non-speciﬁcinteraction with the membrane (phospho)lipids results in disruption
of membrane integrity and eventual disintegration [5].
Antimicrobial peptides are synthesized in granular glands in the
skin of several, although by no means all, species of Anura (frogs and
toads) and represent a source of potential therapeutically valuable
anti-infective drugs [6,7]. These peptides may possess potent and
broad spectrum antimicrobial activity but their therapeutic potential
is often limited by their cytotoxic actions against human cells. The
23 amino acid residue peptide, alyteserin-1c was ﬁrst isolated from
norepinephrine-stimulated skin secretions from the midwife toad
Alytes obstetricans and preliminary data indicated selective growth-
inhibitory activity against Gram-negative bacteria but low haemolytic
activity against human erythrocytes (LC50=220 μM) [8].
This study uses various NMR spectroscopic and molecular modelling
methods to determine the three-dimensional solution structure of
alyteserin-1c and [E4K]alyteserin-1c in various aqueous conditions and
in membrane-mimetic solvent environments. Positional studies of the
peptides in micellar environments were also investigated using para-
magnetic probes. Our data provides insight into the structures of
alyteserin-1c and [E4K]alyteserin-1c that have been useful in the devel-
opment of a peptide analogue with improved therapeutic properties.
2. Materials and methods
2.1. Materials and reagents
DHPC-d22 micelles (1,2-dihexanoyl-sn-glycero-3-phosphocholine)
were purchased from Avanti Polar Lipids (Alabaster, AL, USA).
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dodecyl sulphate (SDS), CD3OH, 2,2,2-triﬂuoroethanol (TFE-d3) and 3-
trimethylsilyl propionic acid (TSP) were obtained from the Sigma-
Aldrich (Ireland). All other chemicals used were of analytical grade.
2.2. Synthesis of the peptide
Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS.NH2) and [E4K]aly-
teserin-1c were supplied in crude form by GL Biochem (Shanghai) Ltd
(China). The peptides were puriﬁed to near homogeneity by reversed-
phase HPLC on a (2.2 cm×25 cm) Vydac 218TP1022 (C-18) column
equilibrated with acetonitrile/water/TFA (28.0/71.9/0.1, v/v/v) at a
ﬂow rate of 6 ml/min. The concentration of acetonitrile was raised
to 56 % (v/v) over 60 min using a linear gradient. Absorbance was
measured at 214 nm and 280 nm and the major peak in the chro-
matogram was collected manually. The ﬁnal purity of the peptides
was N98% and their identity was conﬁrmed by electrospray mass
spectrometry.
2.3. Antibacterial and haemolytic assays
Minimum inhibitory concentrations (MIC) of alyteserin-1c and
[E4K]alyteserin-1c against reference strains of E. coli (ATCC 25922), K.
pneumoniae (ATCC 700603), P. aeruginosa (ATCC 27853), A. baumannii
(Euroclone I NM8), and S. aureus (ATCC 25923) were determined in
duplicate in three independent experiments by a standard microdilu-
tion method using 96-well microtiter cell-culture plates [9]. In order to
monitor the validity and reproducibility of the assays, incubations were
carried out in parallel with increasing concentrations of antibiotics,
ampicillin for E. coli, A. baumannii, and S. aureus and ciproﬂoxacin for
K. pneumoniae and P. aeruginosa. Haemolytic activity against human
erythrocytes taken from a healthy donor was measured as previously
described [7]. The LC50 value was taken as the mean concentration of
peptide producing 50% haemolysis in three incubations.
2.4. NMR spectroscopy
NMR experiments were performed using the 5 mm inverse probe
headonBrukerDRX500NMRspectrometer operating at a 1H resonance
frequency of 500.13 MHz, at 298 K. 1.54 mM peptide samples were
prepared in 550 μl of solvent using water, 10%, 20%, 33% and 50% TFE
(d3)-H2O mixed solvent systems. NMR samples for micellar work were
prepared by mixing 2 mg of peptide with 75 mg of 1,2-dihexanoyl-sn-
glycero-3 phosphatidylcholine-d22 in 90:10=H2O:D2O solvent mix-
ture. This corresponds to a peptide concentration of 1.5 mM and the
peptide to lipid concentration ratio of 1:200. The same protocol was
used for preparing the peptide sample with 50 mg of dodecylpho-
sphocholine and sodium dodecyl sulphate media. 2 μl of 2 mM TSP was
added to the NMR sample for internal referencing. Final volume of the
peptide sample was 550 μl and the pH was uncorrected.
One-dimensional (1D) proton NMR spectra and two-dimensional
(2D) phase-sensitive total correlation spectroscopy (TOCSY) [10],
and nuclear Overhauser effect spectroscopy (NOESY) [11] data sets
were acquired with a relaxation delay of 1.5 s, acquisition time of
0.146 s, and a spectral width of 10 kHz. The TOCSY data were acquired
with 40 ms and 80 ms mixing times, whereas the NOESY data were
acquiredwith a 200 msmixing time. The experimentswere performed
with 16 and 32 transients for each of 2048 t1 increments into 8192
complex data points for the, TOCSY and NOESY data respectively. 2D
data were zero-ﬁlled to 4096 data points in F1 prior to transformation.
All data setswere apodised in both dimensions using a shifted squared
sinebellwindow function. All spectrawere referenced internally to the
residual 1H signal of F3CCDHOD for TFE samples and trimethylsilyl-
propionic acid-d4, sodium salt for aqueous samples, resonating at 3.98
and 0.00 ppm respectively. Data were processed using the Bruker
Topspin program (version 2.1).2.5. Mn2+ and spin-label experiments
The peptide samples (2 mg) were prepared separately by dissol-
ving alyteserin-1c and [E4K]alyteserin-1c in 290 mM deuterated SDS
solution in 90:10=H2O:D2O solvent mixture. This corresponds to a
peptide concentration of 1.54 mM and the peptide to lipid concen-
tration ratio of 1:200 and the ﬁnal volume of 550 μl. Stock solution of
MnCl2 was prepared in 90:10=H2O:D2O solvent mixture and the
NMR experiments were carried out with three concentrations of
MnCl2 (500 μM, 1.66 mM, and 2.30 mM). The pH of the NMR sample
was adjusted to 3.50. The same protocols were followed for the NMR
experiments with the peptide samples in DPC and DHPC (290 mM).
For the spin-label experiments, 5-DSA and 16-DSA were dissolved in
deuterated methanol. The NMR experiments were carried out by
adding different concentrations of stearic acids ranging from 1.15 mM
to 9.45 mM. NMR data collection was carried out 24–48 h after the
sample preparation.
2.6. Structure calculations
2D NMR spectra were analysed and the spectral integration of the
NOESY peaks were done using the SPARKY software version 3.110 [12].
NOESY peak volume integrals were converted into distance constraints
by calibrating of nuclear Overhauser effect (nOe) intensity versus
distance bonds routine of backbone, ﬂexible side-chain and methyl
proton classes with CALIBA [13]. Pseudoatoms were introduced for the
protons which could not be stereospeciﬁcally assigned. Distance
constraints involving ﬁxed distances as well as those limits that could
not be violatedwere regarded as irrelevant by the CYANA program [14].
A set of constraints was thus obtained with upper distance limits as
input for further calculations. Torsional angle constraints in the−90° to
−40° range were also included for 3JHNHαb6.0 Hz. Structure calcula-
tionswere carried out using the CYANA program (version 3.0). Distance
and torsional constraints were used as input to CYANA. Two hundred
structures were randomly generated and energy minimised in CYANA,
including 10,000 steps of simulated annealing, as well as 5,000 steps
of conjugate-gradient minimisation. During the CYANA calculations,
distance and torsional constraints were weighted using the force
constants kNOE=1 kJ mol−1 Å−2 and kDihed_c=5 kJ mol−1 deg−2
respectively. Finally, the20structureswith lowest target functionvalues
were subjected to 1,000 steps of unconstrained Powell minimisation
using the Tripos force ﬁeld within SYBYL (version 6.8.1) [15]. The
Biopolymermodule of TRIPOS software and theMOLMOL(version 2K.2)
[16] graphics packages were used for ﬁnal structure analysis. MOLMOL
and PyMOL (version 0.99) [17] were used for structure representation.
Calculated structures were analysed using the PROCHECK-NMR [18].
3. Results
3.1. Antibacterial and haemolytic activities of alyteserin-1c and [E4K]
alyteserin-1c
The MIC values of synthetic alyteserin-1c and the analogue [E4K]
alyteserin-1c against reference strains of bacteria and their haemolytic
activities against human erythrocytes are shown in Table 1. The growth-
inhibitory potency of [E4K]alyteserin-1c against reference strains of
the clinically relevant Gram-negative bacteria E. coli, P. aeruginosa,
K. pneumoniae and A. baumanniiwas between 2-fold and 4-fold greater
than the naturally occurring peptide. A previous study has shown that
the MIC values against clinical isolates of multidrug-resistant strains
of A. baumannii ranged from 5–10 μM for alyteserin-1c and from 1.25 -
5 μM for [E4K]alyteserin-1c [7]. However, there was no increase in
potency in the case of the Gram-positive bacterium S. aureus. The [E4K]
alyteserin-1c analogue was signiﬁcantly less haemolytic than alyte-
serin-1c (LC50N400 μM compared with 220 μM).
Table 1
Minimum inhibitory concentrations (μM) against reference strains of bacteria and
haemolytic activity (μM) against human erythrocytes of synthetic alyteserin-1c and its
[E4K]alyteserin-1c analogue.
Alyteserin-1c [E4K]alyteserin-1c
E. coli 25 6
K. pneumoniae 50 12.5
P. aeruginosa 25 6
A. baumannii 6 3
S. aureus 250 250
LC50 220 N400
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3.2.1. Alyteserin-1c in an aqueous environment
One dimensional (1D) proton, two dimensional (2D) TOCSY and
NOESY spectra were recorded for the alyteserin-1c in pure water. All
spectra showed poor chemical shift dispersion indicating the lack of
secondary structural features in water. While the NMR data acquired
with 10% and 20% TFE showed no secondary structural features, NMR
samples of 33% and 50% TFE showed clear chemical shift dispersion
and well resolved peaks indicating secondary structure formation and
folding of the peptide chain. As 50% TFE data showed no additional
structural information, data obtained with 33% TFE were used for
further studies. Sequence speciﬁc proton resonance assignment of
alyteserin-1c in 33% TFE was achieved by the analysis of TOCSY and
NOESY spectra. Almost all the spin patterns were unambiguously
assigned in the TOCSY spectrum. The presence ofαiH/Ni+1H and NiH/
Ni+1H cross peaks in the NOESY spectra led to the complete sequence
speciﬁc resonance assignment of the alyteserin-1c peptide in 33% TFE.
The presence of dβN(i,i+1) and dNN(i,i+1) connectivities of
neighbouring amino acid residues supported the reliability of the
resonance assignments. Clear, strong αiH/Ni+3H medium range
connectivities were observed for residues Leu2 through to Ala22
except those between Ser12/Lys15 due to signal overlapping. Most of
theαiH/Ni+4H connectivities were also identiﬁed for residues Leu2 to
Ala22 except for those between Lys15/Ala19 and Ile17/Val21. The strong
αiH/βi+3H medium range connectivities observed for residuesFig. 1. NH/αH region of the NOESY spectra of alyteserin-1c in (A) 33% TFE-water; (B) SDS m
labelled residues.between Leu2and Val21 of the NOESY spectrum conﬁrmed the α-
helical nature of the peptide (Fig. 1).
3.2.2. Alyteserin-1c in SDS and DHPC micellar environments
The secondary structure of alyteserin-1c was determined in SDS
micelles in order to mimic the anionic membrane environment. The
peptide:SDS ratio (c/c) was set up as 1:200 and 1D proton, 2D TOCSY
andNOESY spectrawere collected at307 K. Similar to theNOESYspectra
obtained for the alyteserin-1c in 33% TFE, clear, strong αiH/Ni+3H
medium range connectivities were observed for residues Lys3 through
to Ser23 suggesting the secondary structural elements in the presence of
SDS micelles. Strong αiH/βi+3H medium range connectivities were
identiﬁed between residues Lys3and Val21 except those between Phe6/
Gly9, Ala8/Gly11, Ser12/Lys15, and Val14/Ile17 due to chemical shift
degeneracy. Sequence-speciﬁc resonance assignmentswere carried out,
which led to the full and unambiguous identiﬁcationof all the individual
spin systems. As before,most of theαiH/Ni+4H connectivitieswere also
identiﬁed for residues Lys3 to Val21 which are characteristic nOe
patterns observe for the alpha helical peptides.
1D proton, 2D TOCSY and NOESY spectra were also recorded for
alyteserin-1c in DHPC micelles in order to mimic the zwitterionic
membrane environment. NMR data analysis and data interpretation
showed clear characteristic medium range αiH/Ni+3H connectivities
that were identiﬁed between residues Lys3and Ser23 except between
Ser12/Lys15. Strong clear medium range αiH/βi+3H connectivities
were identiﬁed between residues, Lys3/Phe6, Glu4/Lys7, Lys7/Leu10,
Leu10/Leu13, Gly11/Val14, Ser12/Lys15, Gly16/Ala19, Ala18/Val21 and a
weak Ala19/Ala22 cross peak conﬁrming the presence of stable helical
structure between residues Lys3and Val21. Some of the short and
medium range connectivities could not be identiﬁed due to signal
overlapping. As before, the αiH/Ni+4H connectivities were also
observed indicating characteristic alpha helical nature of the
alyteserin-1c in DHPC micellar media (Fig. 2).
3.2.3. [E4K]alyteserin-1c in DPC and SDS micellar environments
NMR structural studies were carried out for [E4K]alyteserin-1c in
the presence of DPC and SDS micellar media in order to modulate
differences in negatively charged and zwitterionic environments. Theicelles and (C) DHPC micelles. Vertical lines represent the individual spin patterns of
Fig. 2. Short and medium range nOe connectivities for peptide alyteserin-1c in (A) 33%
TFE-water (B) SDS micelles (C) DHPC micelles and for [E4K]alyteserin-1c in (D) DPC
micelles and (E) SDS micelles.
Fig. 3. Solution structure of alyteserin-1c in (A) 33% TFE-water (B) SDS micelles and
(C) DHPC micelles and solution structure of [E4K]alyteserin-1c in (D) DPC micelles and
(E) SDSmicelles showing the ribbon representation of the average solution conformation.
The N-terminus is shown at the bottom for clarity.
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sample and the 1D proton, TOCSY and NOESY spectra were collected
at 307 K. The NOESY spectra obtained for [E4K]alyteserin-1c in SDS
were well resolved and most of the clear medium range αiH/Ni+3H
connectivities were identiﬁed in the ﬁngerprint region except for
Ala8/Gly11 and Lys15/Ala18 due to signal overlap. Strong medium
range αiH/βi+3H connectivities were identiﬁed for those between
Lys3/Phe6, Ile5/Ala8, Gly9/Ser12, Ser12/Lys15, Val14/Ile17, Gly16/Ala19,
Ile17/His20, Ala18/Val21 and Ala18/Alal22. Clear, strong medium range
αiH/Ni+4H connectivities were also identiﬁed between Lys4/Ala8,
Lys7/Gly11, Leu10/Val14, Gly11/Lys15, Val14/Ala18, Ile17/Val21 and Ala18/
Ala22 conﬁrming the presence of an α-helical conformation between
residues Lys3and Ala22.The nOe constraints obtained from the NOESY spectra of [E4K]
alyteserin-1c in DPC media suggested that the peptide forms an alpha
helical structure from Lys3 to Ala22. Clear medium range αiH/Ni+3H
connectivities were identiﬁed except for Lys3/Phe6 and Lys4/Lys7 in the
ﬁngerprint region. Most of the strong αiH/βi+3H medium range con-
nectivities were identiﬁed between residues Lys3and Ala22 conﬁrming
the helical structural component in the presence of DPC micelles.
Characteristic αiH/Ni+4H connectivities for an α-helical peptide were
also identiﬁed in the NOESY ﬁngerprint region between Leu2 and Ala22.
3.3. Molecular modelling
Structure calculations for the alyteserin-1c peptide were performed
based on the nOe constraints obtained for the NOESY spectra in the 33%
TFE-water aqueous environment and the SDS andDHPCmicellarmedia.
For [E4K]alyteserin-1c, structure calculations were performed in DPC
and SDSmedia. An ensemble of 200 structureswas calculated randomly
using the CYANA protocol and the 20 conformations that best ﬁt the
experimental constraints were subjected to additional 1000 steps of
unconstrained Powell energy minimization. The calculated structure
ensembles were then analysed using the PROCHECK-NMR, MOLMOL
and PyMOL software packages. Themain structural feature of the native
peptide is a well deﬁned right handed α-helix between residues
Leu2and Val21 in 33% TFE, and Lys3 to Val21 in the SDS and in DHPC
micelles (Fig. 3). The root-mean square deviation (RMSD) values for a
bestﬁt superposition between residues 3 and 21 of backbone and heavy
atoms were 0.22±0.06 Å and 1.03±0.19 Å for SDS and 0.49±0.27 Å
and 1.17±0.24 Å for DHPC micellar media respectively. All ϕ/ψ values
for non-glycine residues fell into allowed (73.1%), additionally allowed
(26.9%) and zero generously allowed regions for DHPC in the
Ramachandran plot.
The calculated structure of [E4K]alyteserin-1c indicates that the
peptide forms a full length alpha helical conformation between residues
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RMSD values for a best ﬁt superposition between residues 3 and 21 of
backbone and heavy atoms were 0.39±0.12 Å and 1.13±0.23 Å for
DPC and 0.73±0.39 Å and 1.51±0.34 Å for SDS micellar media
respectively. All ϕ/ψ values for non-glycine residues fell into allowed
(69.7%), additionally allowed (29.2%) , generously allowed (1.1%) and
zero in disallowed regions for DPC in the Ramachandran plot (Table 2).
3.4. Positional studies of alyteserin-1c and [E4K]alyteserin-1c with
MnCl2, 5-DSA and 16-DSA
To determine the position of the alyteserin-1c in SDS and DHPC
micelles, Mn2+ ions (MnCl2), 5-DSA and 16-DSAwere incorporated in
to the peptide sample to induce selective broadening of resonances.
For [E4K]alyteserin-1c, positional studies were carried out in DPC and
SDS micellar media with Mn2+ and 5-DSA probes. The 1D proton and
2D TOCSY spectra with and without paramagnetic probes were
recorded and compared to interpret the position of the peptide in the
aqueous phase outside the membrane and within the micelle. To
interpret quantitatively the results with paramagnetic broadening
experiments, NH/αH cross peaks intensities of 2D TOCSY spectra were
obtained using the TOPSPIN program and the remaining peak
intensity/amplitude were calculated after normalizing to the least
affected peak by the corresponding paramagnetic agent. These values
were plotted along the sequence of the peptide (Figs. 4 and 5).
3.4.1. Mn2+ experiments
The peptide samples in SDS (0.5 mM) and DHPC (1.66 mM)
micellar media were titrated with Mn2+ and the NH/αH cross peak
intensity was compared with and without the paramagnetic probes. It
was shown that the TOCSY cross peaks of C-terminal residues His20,
Val21, Ala22 and Ser23 completely disappeared in the SDS medium
while TOCSY cross peaks of Val21, Ala22 and Ser23 also completely
disappeared in DHPC micelles and rest of the residues showed no
effects with Mn2+. Similar results were also obtained for the [E4K]
alyteserin-1c analogue indicating the disappearance of the TOCSY
cross peaks of the C-terminal residues between His20and Ser23.
3.4.2. 5-DSA and 16-DSA experiments
The 5-doxyl stearic acid (5-DSA) and 16-doxyl stearic acid (16-DSA)
were incorporated into the peptide sample at different concentrations,Table 2
Structural statistics of alyteserin-1c (33% TFE, DHPC and SDS) and [E4K]alyteserin-1c (DPC
Alyteserin-1c
33% TFE DHPC
Total nOe constraints 237 202
nOe constraints used 202 176
nOe violationsN0.2 Å 4 1
Ramachandran plot regions (%)
Favoured 90.3 73.1
Additionally allowed 9.7 26.9
Generously allowed 0 0
Mean atomic RMSD (Å)
Backbone atoms (helical) (2–21) (3–21)
0.27±0.09 0.49±0.27
Heavy atoms (helical) 0.99±0.19 1.17±0.24
Average energies(kcal mol-1)
Bond stretching 7.555 7.556
Angle bending 42.756 45.012
Torsional 35.925 37.823
Out of plane bending 0.303 0.378
1–4 Van der Waals 26.12 26.182
Van der Waals -101.79 -96.936
Total 10.868 20.016ranging from 1.15 mM to 9.45 mM. It was shown that the 5-DSA and
16-DSA have similar effects on TOCSY cross peak intensities between
residues Leu2and Ala18 in both SDS and DHPC micellar media while
C-terminal residues His20 to Ser23 showed no effects with these probes.
In DHPC micelles, when 1.15 mM of either 5-DSA or 16-DSA were
incorporated into the peptide sample, NH/αHcross peak intensitieswere
slightly reduced for residues between Leu2and Ala18, whereas Val14 and
Ala18 showed a remarkable reduction in peak intensities due to peak
height reduction. The NH/αH cross peak intensities for residues Glu4, Ile5
and Lys15 could not be evaluated due to the signal overlapping. Upon
increasing the spin label concentrationof 5-DSAor16-DSAup to4.70 mM
(Fig. 4),αH-NHcross peaks in theﬁngerprint region of the TOCSY spectra
completely disappeared except for Ala8, Ser12 which showed reduced
intensity and the C-terminal residues His20 to Ser23 showed no effect.
When 5-DSA was introduced into the SDS peptide sample, peak
intensities of NH/αH TOCSY cross peaks between residues Leu2and
Ala18 were reduced, but there were no clear disappearances of cross
peaks in the ﬁnger print region as observed with DHPC micelles. The
peak intensities for Glu4, Ile5, Ala8, Gly9, Gly11 and Ser12 could not be
obtained due to signal overlapping. At low concentration of 16-DSA, the
peak intensitieswere slightly reducedwhereas, Phe6, Lys7, and residues
Val14 and Lys15 showed a remarkable reduction of peak intensity when
increasing the spin label concentration up to 4.70 mM (Fig. 4). These
peaks completely disappeared when increasing the 16-DSA concentra-
tion (data not shown). As before, C-terminal residues His20 to Ser23
showed no effect with 5-DSA and 16-DSA in SDS micelles.
TOCSY experiments were carried out for [E4K]alyteserin-1c using
different concentrations of 5-DSA in SDS and DPCmicellarmedia. It was
clear that the N-terminal residues were affected by the 5-DSA up to
Ala18. TheC-terminal residuesbetweenHis20and Ser23 didnot showany
intensity changes of the TOCSY cross peaks. When 5-DSA was
incorporated into the SDS micellar samples, TOCSY cross peak
intensities were reduced from Leu2 to Ala18. The intensities of Lys3,
Lys7, Leu13 and Ala19 cross peaks could not be evaluated due to signal
overlapping. For the [E4K]alyteserin-1c analogue in DPC, residues, Leu2,
Lys3, Phe6, Lys7, Val14, Ile17 and Ala18 were affected upon increasing the
5-DSA concentration. At high concentration of 5-DSA (9.6 mM), the
TOCSY cross peaks of the N-terminal residues Leu2 and Lys3 completely
disappeared in the ﬁngerprint region of the TOCSY spectra while the
intensities of other residues were remarkably reduced when compared
to the intensities at lower concentrations of 5-DSA.and SDS) micelles.
[E4K]alyteserin-1c
SDS DPC SDS
221 204 205
161 156 159
2 5 4
75.6 69.7 80.0
24.4 29.2 15.3
0.7 1.1 4.7
(3–21) (3–21) (3–21)
0.22±0.06 0.39±0.12 0.73±0.39
1.03±0.19 1.19±0.23 1.51±0.34
7.592 7.896 7.945
46.133 44.562 44.778
36.84 35.340 37.227
0.327 0.428 0.294
20.067 27.015 27.486
-100.212 -95.801 -101.384
16.746 19.440 16.347
Fig. 4. 500 MHz superimposed TOCSY spectra of alyteserin-1c and [E4K]alyteserin-1c (1.54 mM) in 290 mM SDS, DPC and DHPC micellar media with and without paramagnetic
agents. (4A) alyteserin-1c; 500 μMMnCl2 in SDS, (4B) alyteserin-1c; 2.36 mM 16-DSA in SDS, (4 C) alyteserin-1c; 4.70 mM 16-DSA in SDS, (4D) [E4K]alyteserin-1c; 4.70 mM 5-DSA
in SDS, (4E) alyteserin-1c; 1.66 mMMnCl2 in DHPC, (4 F) alyteserin-1c; 2.36 mM 16-DSA in DHPC, (4 G) alyteserin-1c; 4.70 mM 16-DSA in DHPC, (4 H) [E4K]alyteserin-1c; 4.70 mM
5-DSA in DPC. All the NH/αH cross peaks were labelled with the residue number.
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Fig. 5. Remaining amplitudes of NH/αH TOCSY cross peaks of alyteserin-1c in 290 mM SDS and DHPCmicellar media after addition of paramagnetic agents. (A) Remaining amplitude
when 2.36 mM and 4.70 mM 16-DSA are added to the SDS sample (B) remaining amplitude when 500 μMMnCl2 is added to the SDS sample (C) remaining amplitude when 1.15 mM
and 2.36 mM 16-DSA is added to the DHPC sample and (D) remaining amplitude when 1.66 mM MnCl2 is added to the DHPC sample.
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In common with many bioactive peptides, such as peptide
hormones and antimicrobial peptides, alyteserin-1c does not show
any secondary structural features in aqueous medium. In 33% and 50%
TFE-water mixed solvent systems, alyteserin-1c adopts an alpha
helical conformation with a stable secondary structure between
residues Ile2and Val21. It has been shown that low molecular weight
ﬂuorinated alcohols, such as TFE, may increase the amount of helical
structure content of a peptide when they are added to an aqueous
solution [19–22]. Fluorinated alcohols alter the electrostatic in-
teractions within and between the peptide molecules and also tend
to accumulate near the surface of the polypeptide. Consequently, they
produce effects on water-solvent exposed groups, such as carbonyl
and amide groups, favouring the intermolecular hydrogen bond
formation which stabilizes the helical conformation [23].
In order to probe the structural basis for its speciﬁc actions against
negatively charged bacterial membrane and zwitterionic mammalian
membrane systems, the NMR solution structure of alyteserin-1c was
investigated in SDS and DHPC micellar media, respectively. These
micellar systems have served as membrane mimetic environments
since the early NMR structure determination of biopolymers [24,25].
They are used asmonolayers or bilayers tomimic biologicalmembranes
in NMR spectroscopic studies [26,27]. In particular, SDS micelles are
used to mimic the bacterial cell membrane as it consists of a negatively
charged outer surface and a hydrophobic inner core [28,29]. Similarly,
DHPC micelles are used to mimic eukaryotic membrane systems that
contain a higher proportion of zwitterionic phospholipids [5]. In both
micellar systems, alyteserin-1c formed a well-deﬁned amphipathic
helical structure with similar backbone conformation between residues
Lys3 and Val21. The side-chain orientations of the conformation vary
slightly with SDS and DHPC media suggesting that alyteserin-1c may
interact differently with the two micellar systems.
The three dimensional structure of the [E4K]alyteserin-1c
analogue has also been determined in the presence of anionic SDSand zwitterionic DPCmicelles. The calculated structure indicates that
the active peptide forms a full length alpha helical conformation
between residues Lys3 and Val21 in both environments. The NMR and
molecular modelling studies conﬁrmed that the alyteserin-1c and
the active peptide analogue, [E4K]alyteserin-1c, consist of an
identical helical segment from residues Lys3 to Val21. However,
side chain orientations of these peptides were different as seen in
Fig. 3.
To investigate the interaction of the peptide with the various
membrane environments, NMR paramagnetic experiments were
performed with three different paramagnetic probes. In the aqueous
phase, Mn2+ ions are expected to cause broadening of resonances of
amino acid residues exposed to the solvent and near to the surface of
micellar membrane. It is known that the doxyl stearic acids affect the
inside the micellar membrane. When 5-DSA is incorporated, broad-
ening of the resonances occurs near to the micellar boundary due to
the free radical group positioned inside the micelles close to the
membrane surface whereas the spin label of 16-DSA is positioned
near to the centre of the micelles which will result in the reduction of
peak intensity [30–32].
In SDS micelles, the C-terminal residues of alyteserin-1c are
strongly affected by Mn2+ with cross peaks of His20 to Ser23
completely disappearing in the 2D TOCSY spectra suggesting that
these residues lie outside or at the surface of the membrane. This is
apparent from the remaining amplitude (Fig. 5B). Literature reports
suggest that there could be a marked difference of broadening of the
cross peak resonances when considering the effect of 5-DSA and 16-
DSA in membrane environments [26,33]. Apart from the Gly1 and
Leu2 residues at the beginning of the N-terminal region, most of the
amino acids from Lys3 to Ala18 are strongly affected by both probes.
This may be explained by the fact that the micelle molecules in the
solution are mobile and are continuously changing their position and
shape. Due to the ﬂexibility of micelle molecules and the hydrophobic
tail of stearic acid, the effect of these two probes cannot be clearly
distinguished. This resulted in a similar broadening effect for most of
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In DHPC micelles, the cross peak resonances of the His20 residue
showed reduced cross peak intensity and the cross peaks Val21, Ala22
and Ser23 completely disappeared from the TOCSY spectra when
MnCl2 was added to the peptide samples, conﬁrming that these
residues reside outside or at the surface of the membrane. Calculated
remaining amplitudes conﬁrm that residues Val21 to Ser23 in the C-
terminal region lie completely outside of the micelle (Fig. 5D). At
higher concentrations of 16-DSA (2.36 mM), strong effects on the
cross peak resonances were observed. In particular, cross peak
resonances of Phe6, Gly9, Leu10, and Gly11 completely disappeared
in the TOCSY spectra while the cross peak resonances of the
hydrophilic residues Lys3, Lys7, Ser12 and Lys15 were less affected. It
is clear from the helical-wheel representation of the peptide that
these residues are localized to one face of the helix (Fig. 6). It may be
argued, therefore, that the peptide maintains its amphipathic nature
when interacting with a membrane environment.
When the 16-DSA concentration is increased to 4.70 mM, cross
peak resonances from residues Leu2 to Lys7 completely disappeared
but not those of Ala8 and Ser12 (Figs. 4F, G and 5C). According to these
paramagnetic broadening studies, it is clear that alyteserin-1c is
located inside the micelles up to residue Ala18 with the hydrophobic
residues facing the interior of the micelle and the hydrophilic residues
facing the exterior of the membrane. All the studies indicate that
the C-terminal domain from His20 to Ser23 is located outside the
membrane residing in the solvent environment. Fig. 7 shows how
alyteserin-1c could interact with the micellar environment.
With Mn2+ probe studies, the more potent analogue, [E4K]
alyteserin-1c showed similar results as the parent peptide, alyte-
serin-1c in both SDS and DPCmicellar environments showing that the
C-terminal residues His20 to Ser23 lie outside of the micelle. TheFig. 6. Helical wheel representation and the solution structure of alyteserin-1c (6A) in DHPC
the amphipathic character and side chain orientation. The ﬁgures depict the hydrophobic
bottom.paramagnetic probe studies of [E4K]alyteserin-1c with 5-DSA showed
a general reduction in cross peak intensity between residues Leu2and
Ala18 while the peak intensities for Glu4, Ala8, Ser12 and Gly16 were
not affected to the same degree for those signals that are not
overlapping. For alyteserin-1c in DHPC, the oscillating behaviour of
the remaining amplitude, which is most pronounced in the 2.36 mM
concentration of 16-DSA, increases for residues Ala8, Ser12 and Gly16
and decreases in between these residues (Fig. 5). A similar but less
pronounced pattern can be seen for alyteserin-1c in SDS. However,
due to signal overlap only residues Glu4, Ser12 and Gly16 could be
examined (Fig. 5A). For [E4K]alyteserin-1c a similar trend can also be
seen when the TOCSY cross peaks intensities for residues Lys4, Ala8,
Ser12 are examined (data not shown). These results indicate that
residues Glu4/Lys4, Ala8, Ser12 and Gly16 could be closer to the
hydrophilic face of the amphiphathic alpha helix suggesting that the
peptides lie with the hydrophilic side facing outwards the micelle
head groups (Fig. 6). However it is not possible to determine how
deeply the peptide is inserted into the micelle due to the ﬂexible
nature of the DSA and the micelle molecules [26].
The micellar systems that have been used for these studies are
frequently used for paramagnetic experiments to probe the confor-
mations of antimicrobial peptides. In particular SDS is used to mimic
anionic prokaryotic membrane systems whereas DHPC and DPC are
normally used as a zwitterionic membrane model. Literature reports
suggest that these micelle systems form a spherical shape with a
diameter of 40–50 Å [29,33–35]. However, the DHPC micelle may be
more accurately modelled as a barrel with the molecules arranged
cylindrically around it [35]. It has also been reported that these
micelle systems can change their shape in free solution due to the
ﬂexibility of the micelle molecules [26]. According to our paramag-
netic experiments, it was clear that both alyteserin-1c and [E4K]
alyteserin-1c peptides inserted in to the micelle membrane up tomicellar medium and [E4K]alyteserin-1c (6B) in SDS micellar medium demonstrating
(red) and hydrophilic (blue) domains of the peptides showing the N-terminus at the
Fig. 7. Schematic representation of alyteserin-1c in a micellar environment consistent with the results obtained with paramagnetic agents. The NMR derived solution conformation of
alyteserin-1c is shownwith a ribbon representation and labelled hydrophilic residues. Residue 19 is at the surface of themicellewhile C-terminal residues 20–23 lie outside of themicelle.
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size of the micelle should be large enough to accommodate the
peptide inside the micelle.
It is concluded, therefore, that in both micellar systems, Mn2+ ions
have effects on the C-terminal residues from His20 to Ser23 conﬁrming
that the C-terminal region is exposed to the aqueous medium and is
not interacting with the membrane. Studies of alyteserin-1c with 5-
DSA and 16-DSA showed similar TOCSY cross peak intensity changes
conﬁrming that the N-terminal and central residues between Leu2and
Ala18 lie inside the micelle. Similar results were also observed for the
paramagnetic probe studies of [E4K]alyteserin-1c showing that
residues Leu2 to Ala18 reside inside the micelle environment. These
results conﬁrm that the different segments of the alyteserin-1c and
[E4K]alyteserin-1c molecules interact similarly with the micelle
environments and the peptides are inserted into the membrane
with the C-terminal end not interacting with themicelles. However, in
terms of secondary structure, NMR structural studies of these peptides
in micellar environments did not show any clear indication of why an
increase in biological activity of the analogue peptide was observed.
Probably, experiments in the presence of lipids instead of micelles
would have been more appropriate to do the structural studies of
these peptides and to get a structural interpretation of the differences
in biological activity of these peptides.
Carbapenems are among the few useful antibiotics against multi-
drug resistant Gram-negative bacteria so that the emergence of
Enterobacteriaceae strains producing metallo-beta lactamases, such
as the NDM-1 enzyme, capable of hydrolysing carbapenems and
structurally related agents seriously limits treatment options [36]. A
previous study has shown that the frog skin peptide ascaphin-
8 potently (MIC≤25 μM) inhibits growth of strains of extended
spectrum beta-lactamase (ESBL)-producing E. coli and K. pneumoniae
[37]. This present study identiﬁes alyteserin-1c as a second candidate
for development into an agent for treatment of infections produced by
beta lactamase-producing Gram-negative bacteria. The demonstra-
tion that residues Leu2 to Lys7 of the peptide are of particular
importance in interaction with the bacterial cell membrane has
facilitated the design of an analogue ([E4K]alyteserin-1c) withincreased antimicrobial potency against reference strains of these
pathogens and against P. aeruginosa and A. baumannii (Table 1).
The antimicrobial potency of a peptide against microorganisms
and its cytotoxicity against mammalian cells, such as erythrocytes, is
determined by complex interactions among cationicity, hydropho-
bicity, α-helicity and amphipathicity [5]. Studies with a range of
naturally occurring and model peptides (reviewed in [38]) have
shown that an increase in peptide cationicity promotes interaction
with the negatively charged (phospho)lipids in the bacterial cell
membrane and so increases antimicrobial potency. In contrast, the
plasmamembrane of eukaryotic cells, such as erythrocytes, contains a
higher proportion of zwitterionic phospholipids and similar studies
with a range of antimicrobial peptides have indicated that increasing
overall hydrophobicity increases cytotoxicity against mammalian
cells. Consequently, the increase in peptide cationicity associated with
the substitution Glu4→Lys in the critically important Leu2 to Lys7
region of the peptide promotes stronger interaction with the
negatively charged bacterial cell membrane and so results in
increased antibacterial activity. The haemolytic activity of the [E4K]
alyteserin-1c analogue is signiﬁcantly lower than the naturally
occurring peptide (LC50N400 μM vs 220 μM) which may be a
consequence of the small decrease in hydrophobicity associated
with a lysine side-chain compared with a glutamic acid side-chain
[39].
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